+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mice Model Market - Global Forecast 2026-2032- Product Image
Mice Model Market - Global Forecast 2026-2032- Product Image
Sale

Mice Model Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4829830
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mice Model Market is projected to reach USD 1.88 Billion in 2026. It is expected to continue growing at a CAGR of 8.66%, reaching USD 3.11 Billion by 2032.

The mice model market remains a foundational pillar of preclinical research because laboratory mouse models provide genetically tractable, reproducible, and biologically relevant systems for studying human disease. Mouse and human biology share extensive genetic and physiological similarities, supporting continued use in oncology, immunology, metabolic disease, neuroscience, infectious disease, toxicology, and vaccine research.

For preclinical model providers and contract research organizations, demand is increasingly concentrated around humanized mice, transgenic mice, knockout mice, patient-derived xenograft models, germ-free models, immunodeficient strains, and disease-specific in vivo platforms. Buyers are prioritizing validated phenotypes, reproducible background strains, strong animal welfare compliance, defined microbial status, and faster study turnaround as drug developers seek higher-confidence translational evidence before clinical investment.

Transformative Shifts in the Mice Model Landscape

The mice model landscape is shifting from standardized colony supply toward specialized, data-rich preclinical solutions. CRISPR-Cas9 genome editing has accelerated the creation of targeted knockout, knock-in, conditional, and reporter mouse models, while humanized immune system models and patient-derived xenograft platforms are expanding their role in oncology, immuno-oncology, autoimmune disease, and infectious disease testing.

Regulatory and ethical expectations are also reshaping purchasing behavior. The 3Rs principles of replacement, reduction, and refinement, ARRIVE reporting guidelines, and institutional animal care standards are pushing providers to document welfare practices, genetic integrity, microbial status, study reproducibility, and endpoint justification. This transformation favors partners that combine scientific customization with transparent quality systems and robust in vivo research governance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler across the mice model value chain. AI-supported image analysis, automated behavioral tracking, digital pathology, high-content phenotyping, and longitudinal monitoring help reduce observer bias and extract more endpoints from each study, supporting the reduction principle within the 3Rs framework.

For model providers, AI also improves colony management, breeding forecasts, genotype-phenotype interpretation, and study design optimization. Predictive analytics can help identify appropriate cohort structures, reduce failed breeding cycles, flag welfare anomalies, and detect outliers earlier. The strongest commercial advantage will come from integrating AI with validated wet-lab workflows, controlled experimental design, and expert biological interpretation rather than positioning algorithms as substitutes for translational evidence.

Key Regional Insights for Mice Model Providers

North America remains a leading hub for mice model services due to its dense concentration of biopharmaceutical R&D, NIH-funded academic research, advanced vivarium infrastructure, and established contract research capabilities. Europe continues to emphasize welfare-driven innovation through EU Directive 2010/63/EU, rigorous ethical review, and broad adoption of the 3Rs, while maintaining strong demand for genetically engineered mouse models, oncology models, immunology platforms, and pharmacology studies.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and Singapore invest in translational medicine, genome editing, oncology research infrastructure, and regulated preclinical capabilities. Latin America is led by Brazil and Mexico in biomedical research capacity, infectious disease studies, and academic animal research programs, while the Middle East is building biomedical clusters, precision medicine initiatives, and hospital-linked research programs across the GCC. Africa remains earlier stage but is gaining relevance through infectious disease research, public health collaborations, vaccine-related studies, and university-led laboratory animal programs that support region-specific biomedical priorities.

Key Group Insights Across Research Blocs

ASEAN markets are increasingly important for preclinical outsourcing as Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines strengthen biomedical research ecosystems, laboratory capacity, and multinational academic collaborations. GCC countries are investing in precision medicine, academic medical centers, genomics programs, and healthcare innovation strategies, creating selective demand for high-quality animal research partnerships, imported specialized strains, and compliant preclinical testing support.

The European Union sets a global benchmark for animal welfare governance, data transparency, harmonized compliance, and structured ethical assessment under Directive 2010/63/EU. BRICS countries, especially China, India, and Brazil, are expanding domestic capabilities in genetic engineering, disease modeling, biomanufacturing-linked research, and translational medicine. G7 markets remain premium buyers of validated mice models due to mature biopharmaceutical pipelines, strong academic funding, and advanced regulatory expectations, while NATO-aligned countries benefit from biomedical security, infectious disease preparedness, trauma research, and defense-related medical research priorities that sustain demand for reliable in vivo models.

Key Country Insights in the Mice Model Market

The United States is the largest strategic market for advanced mice model services, supported by NIH funding, biopharma pipelines, specialized vivarium infrastructure, and mature CRO capacity. Canada contributes strong academic research, translational medicine networks, and ethical oversight, while Mexico supports regional research, manufacturing-linked life sciences activity, and growing clinical and biomedical collaboration. Brazil leads Latin America through major universities, biomedical institutes, infectious disease expertise, and established public research systems.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand for transgenic mice, knockout models, oncology models, and disease-specific platforms under strict animal welfare systems, while Russia retains scientific capacity in biomedical research despite geopolitical and collaboration constraints. China is scaling domestic model production, CRISPR capabilities, humanized mouse platforms, and oncology research capacity; India is expanding translational research, vaccine development, and pharmacology capabilities; Japan and South Korea remain advanced innovation hubs for regenerative medicine, immunology, oncology, and precision research; and Australia supports immunology, oncology, neuroscience, and infectious disease research through well-regulated institutions and strong university-led biomedical programs.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize model validation, genetic authentication, microbial and microbiome control, environmental standardization, and transparent study documentation as core differentiators. Providers that can demonstrate reproducibility across sites, ethical compliance, robust quality assurance, and clinically relevant endpoints will be better positioned for high-value partnerships with pharmaceutical, biotechnology, academic, and government research clients.

Commercial teams should invest in humanized models, patient-derived xenograft libraries, CRISPR-enabled custom model generation, germ-free and gnotobiotic capabilities, and AI-enhanced phenotyping. Partnerships with academic disease centers, biobanks, and translational research networks can strengthen scientific credibility. Vendors should also communicate 3Rs-aligned study design, because buyers increasingly view welfare, data integrity, operational efficiency, and regulatory readiness as linked performance indicators in preclinical research outsourcing.

Research Methodology

This executive summary is built from verified industry knowledge across preclinical research, laboratory animal science, genome engineering, regulatory guidance, biomedical R&D trends, and translational medicine practices. The analysis reflects established frameworks including the 3Rs principles, ARRIVE reporting guidance, EU animal research rules, institutional animal care and use requirements, and recognized practices in genetically engineered, immunodeficient, germ-free, and humanized mouse model development.

Market interpretation focuses on evidence-backed demand drivers rather than speculative claims. Regional, group, and country insights are assessed through observable research capacity, biopharmaceutical activity, regulatory maturity, academic infrastructure, public health priorities, and translational medicine investment.

Conclusion

The mice model market is evolving from a commodity animal supply segment into a precision preclinical research ecosystem. Industry direction is being shaped by humanized models, CRISPR-edited strains, patient-derived xenograft platforms, oncology and immunology applications, infectious disease research, AI-enabled phenotyping, and rising expectations for reproducible, welfare-conscious science.

For providers and CROs, competitive advantage will depend on scientific depth, operational quality, data transparency, animal welfare alignment, and the ability to comply with global research standards. Organizations that integrate ethical animal research with advanced disease modeling, controlled study design, and digital analytics will be best positioned to serve the next generation of translational medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mice Model Market, by Model Type
7.1. Introduction
7.2. Genetically Engineered Mice Models
7.2.1. Conditional Knockout Models
7.2.2. Humanized Mice Models
7.2.3. Knockout Models
7.2.4. Transgenic Models
7.3. Inbred Mice Models
7.4. Outbred Mice Models
8. Mice Model Market, by Age Cohort
8.1. Introduction
8.2. Embryonic
8.3. Neonatal
8.4. Juvenile
8.5. Adult
8.6. Aged
9. Mice Model Market, by Procurement Format
9.1. Introduction
9.2. Live Animals
9.2.1. Experimental Cohorts
9.2.2. Breeding Stock
9.2.3. Timed-Pregnant Females
9.3. Cryopreserved Materials
9.3.1. Embryos
9.3.2. Sperm
10. Mice Model Market, by Disease Induction Method
10.1. Introduction
10.2. Spontaneous Models
10.3. Chemically Induced Models
10.4. Diet-Induced Models
10.5. Surgically Induced Models
10.6. Infection-Induced Models
11. Mice Model Market, by Application
11.1. Introduction
11.2. Behavioral Studies
11.3. Cardiovascular Diseases
11.4. Drug Discovery & Toxicology
11.5. Genetic Disease Research
11.6. Immunology
11.7. Infectious Diseases
11.8. Metabolic Disorders
11.9. Neurology & Neurodegenerative Diseases
11.10. Oncology Research
12. Mice Model Market, by End User
12.1. Introduction
12.2. Academic & Research Institutions
12.3. Contract Research Organizations (CROs)
12.4. Hospitals & Diagnostic Centers
12.5. Pharmaceutical & Biotechnology Companies
13. Mice Model Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Mice Model Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Mice Model Market, by Country
15.1. United States
15.2. Germany
15.3. China
15.4. United Kingdom
15.5. India
15.6. Japan
15.7. Russia
15.8. Brazil
15.9. Canada
15.10. Italy
15.11. Mexico
15.12. France
15.13. Spain
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Applied StemCell, Inc.
17.2. Aragen Life Sciences Ltd.
17.3. Biocytogen Boston Corporation
17.4. Charles River Laboratories International, Inc.
17.5. Creative Biolabs
17.6. Crown Bioscience by JSR Life Sciences, LLC
17.7. Cyagen Biosciences Suzhou Inc.
17.8. Cyagen US Inc. by PolyGene AG
17.9. Envigo by Inotiv, Inc.
17.10. GemPharmatech Co., Ltd.
17.11. GenOway
17.12. Harbour BioMed
17.13. Hera BioLabs, Inc.
17.14. inGenious Targeting Laboratory, Inc.
17.15. Janvier Labs
17.16. Marshall BioResources
17.17. MD Biosciences
17.18. Mirimus, Inc.
17.19. Ozgene Pty Ltd.
17.20. PhoenixBio Co., Ltd.
17.21. Shanghai Model Organisms Center, Inc.
17.22. Taconic Biosciences, Inc.
17.23. The Jackson Laboratory
17.24. TransCure bioServices
17.25. Translational Drug Development, LLC
17.26. Urosphere SAS
17.27. Vitalstar Biotechnology Co., Ltd.
17.28. XenOPAT SL by Bellvitge Biomedical Research Institute
List of Figures
FIGURE 1. GLOBAL MICE MODEL MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MICE MODEL MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MICE MODEL MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MICE MODEL MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MICE MODEL MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MICE MODEL MARKET SIZE, BY AGE COHORT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MICE MODEL MARKET SIZE, BY AGE COHORT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MICE MODEL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MICE MODEL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MICE MODEL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL MICE MODEL MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MICE MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL GENETICALLY ENGINEERED MICE MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL GENETICALLY ENGINEERED MICE MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL GENETICALLY ENGINEERED MICE MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CONDITIONAL KNOCKOUT MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CONDITIONAL KNOCKOUT MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CONDITIONAL KNOCKOUT MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HUMANIZED MICE MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HUMANIZED MICE MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HUMANIZED MICE MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL KNOCKOUT MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL KNOCKOUT MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL KNOCKOUT MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL TRANSGENIC MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TRANSGENIC MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSGENIC MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL INBRED MICE MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL INBRED MICE MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL INBRED MICE MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL OUTBRED MICE MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL OUTBRED MICE MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL OUTBRED MICE MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL EMBRYONIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL EMBRYONIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL EMBRYONIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL JUVENILE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL JUVENILE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL JUVENILE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AGED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AGED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AGED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LIVE ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LIVE ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL LIVE ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL EXPERIMENTAL COHORTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL EXPERIMENTAL COHORTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL EXPERIMENTAL COHORTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL BREEDING STOCK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BREEDING STOCK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BREEDING STOCK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TIMED-PREGNANT FEMALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TIMED-PREGNANT FEMALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TIMED-PREGNANT FEMALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CRYOPRESERVED MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CRYOPRESERVED MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CRYOPRESERVED MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL EMBRYOS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL EMBRYOS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL EMBRYOS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SPERM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SPERM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SPERM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SPONTANEOUS MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SPONTANEOUS MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SPONTANEOUS MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CHEMICALLY INDUCED MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CHEMICALLY INDUCED MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CHEMICALLY INDUCED MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DIET-INDUCED MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL DIET-INDUCED MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DIET-INDUCED MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SURGICALLY INDUCED MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SURGICALLY INDUCED MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SURGICALLY INDUCED MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL INFECTION-INDUCED MODELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL INFECTION-INDUCED MODELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL INFECTION-INDUCED MODELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BEHAVIORAL STUDIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL BEHAVIORAL STUDIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL BEHAVIORAL STUDIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG DISCOVERY & TOXICOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG DISCOVERY & TOXICOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG DISCOVERY & TOXICOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL GENETIC DISEASE RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GENETIC DISEASE RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GENETIC DISEASE RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL NEUROLOGY & NEURODEGENERATIVE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL NEUROLOGY & NEURODEGENERATIVE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL NEUROLOGY & NEURODEGENERATIVE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. EUROPE MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. EUROPE MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 154. EUROPE MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 155. EUROPE MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 156. EUROPE MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 157. EUROPE MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 158. EUROPE MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 159. EUROPE MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 160. EUROPE MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. AFRICA MICE MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. AFRICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 173. AFRICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 174. AFRICA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 175. AFRICA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 176. AFRICA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 177. AFRICA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 178. AFRICA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 179. AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. AFRICA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. ASEAN MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. ASEAN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 184. ASEAN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 185. ASEAN MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 186. ASEAN MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 187. ASEAN MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 188. ASEAN MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 189. ASEAN MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 190. ASEAN MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. ASEAN MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. GCC MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. GCC MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 194. GCC MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 195. GCC MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 196. GCC MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 197. GCC MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 198. GCC MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 199. GCC MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 200. GCC MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. GCC MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. BRICS MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. BRICS MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 214. BRICS MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 215. BRICS MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 216. BRICS MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 217. BRICS MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 218. BRICS MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 219. BRICS MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 220. BRICS MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. BRICS MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. G7 MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. G7 MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 224. G7 MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 225. G7 MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 226. G7 MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 227. G7 MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 228. G7 MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 229. G7 MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 230. G7 MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. G7 MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. NATO MICE MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. NATO MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 234. NATO MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 235. NATO MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 236. NATO MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 237. NATO MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 238. NATO MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 239. NATO MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 240. NATO MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 241. NATO MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. GERMANY MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 254. GERMANY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 255. GERMANY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 256. GERMANY MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 257. GERMANY MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 258. GERMANY MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 259. GERMANY MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 260. GERMANY MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 261. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. GERMANY MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. CHINA MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. CHINA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 265. CHINA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 266. CHINA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 267. CHINA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 268. CHINA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 269. CHINA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 270. CHINA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 271. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. CHINA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. INDIA MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. INDIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 285. INDIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 286. INDIA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 287. INDIA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 288. INDIA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 289. INDIA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 290. INDIA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 291. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. INDIA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. JAPAN MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. JAPAN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 295. JAPAN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 296. JAPAN MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 297. JAPAN MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 298. JAPAN MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 299. JAPAN MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 300. JAPAN MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 301. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 302. JAPAN MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 306. RUSSIA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 307. RUSSIA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 308. RUSSIA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 309. RUSSIA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 310. RUSSIA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 311. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 312. RUSSIA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 314. BRAZIL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 315. BRAZIL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 316. BRAZIL MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 317. BRAZIL MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 318. BRAZIL MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 319. BRAZIL MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 320. BRAZIL MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 321. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. BRAZIL MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. CANADA MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 324. CANADA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 325. CANADA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 326. CANADA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 327. CANADA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 328. CANADA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 329. CANADA MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 330. CANADA MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 331. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. CANADA MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 333. ITALY MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 334. ITALY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 335. ITALY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 336. ITALY MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 337. ITALY MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 338. ITALY MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 339. ITALY MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 340. ITALY MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 341. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 342. ITALY MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 343. MEXICO MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 344. MEXICO MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 345. MEXICO MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 346. MEXICO MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 347. MEXICO MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 348. MEXICO MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 349. MEXICO MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 350. MEXICO MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 351. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. MEXICO MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 353. FRANCE MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 354. FRANCE MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 355. FRANCE MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 356. FRANCE MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 357. FRANCE MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 358. FRANCE MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 359. FRANCE MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 360. FRANCE MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 361. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 362. FRANCE MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. SPAIN MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 364. SPAIN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 365. SPAIN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 366. SPAIN MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 367. SPAIN MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 368. SPAIN MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 369. SPAIN MICE MODEL MARKET SIZE, BY CRYOPRESERVED MATERIALS, 2017-2032 (USD MILLION)
TABLE 370. SPAIN MICE MODEL MARKET SIZE, BY DISEASE INDUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 371. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 372. SPAIN MICE MODEL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 373. AUSTRALIA MICE MODEL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 374. AUSTRALIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2017-2032 (USD MILLION)
TABLE 375. AUSTRALIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2017-2032 (USD MILLION)
TABLE 376. AUSTRALIA MICE MODEL MARKET SIZE, BY AGE COHORT, 2017-2032 (USD MILLION)
TABLE 377. AUSTRALIA MICE MODEL MARKET SIZE, BY PROCUREMENT FORMAT, 2017-2032 (USD MILLION)
TABLE 378. AUSTRALIA MICE MODEL MARKET SIZE, BY LIVE ANIMALS, 2017-2032 (USD MILLION)
TABLE 379. AUSTR

Companies Mentioned

  • Applied StemCell, Inc.
  • Aragen Life Sciences Ltd.
  • Biocytogen Boston Corporation
  • Charles River Laboratories International, Inc.
  • Creative Biolabs
  • Crown Bioscience by JSR Life Sciences, LLC
  • Cyagen Biosciences Suzhou Inc.
  • Cyagen US Inc. by PolyGene AG
  • Envigo by Inotiv, Inc.
  • GemPharmatech Co., Ltd.
  • GenOway
  • Harbour BioMed
  • Hera BioLabs, Inc.
  • inGenious Targeting Laboratory, Inc.
  • Janvier Labs
  • Marshall BioResources
  • MD Biosciences
  • Mirimus, Inc.
  • Ozgene Pty Ltd.
  • PhoenixBio Co., Ltd.
  • Shanghai Model Organisms Center, Inc.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TransCure bioServices
  • Translational Drug Development, LLC
  • Urosphere SAS
  • Vitalstar Biotechnology Co., Ltd.
  • XenOPAT SL by Bellvitge Biomedical Research Institute

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.88 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.11 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Medical Keyboards, Medical Mice Market - Global Forecast 2026-2032 - Product Image

Medical Keyboards, Medical Mice Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Mice Model - Global Strategic Business Report - Product Image

Mice Model - Global Strategic Business Report

  • Report
  • 385 Pages
  • Global
From
Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030 - Product Image

Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030

  • Report
  • 446 Pages
  • Global
From
Mice Model Market Outlook 2026-2034: Market Share, and Growth Analysis by Type, Application, End User, Technology - Product Image

Mice Model Market Outlook 2026-2034: Market Share, and Growth Analysis by Type, Application, End User, Technology

  • Report
  • 160 Pages
  • Global
From
Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 183 Pages
  • Global
From

About the Mouse Model Market

The Mouse Model market is a subset of the biotechnology industry that focuses on the development and use of laboratory mice for research purposes. Mouse models are used to study a variety of biological processes, including gene expression, disease progression, and drug efficacy. These models are created by introducing genetic modifications into the mouse genome, which can be used to study the effects of a particular gene or mutation. Mouse models are also used to study the effects of environmental factors, such as diet, on health and disease. The Mouse Model market is highly competitive, with a variety of companies offering a range of services. These include the development of custom mouse models, the production of transgenic mice, and the provision of mouse model-related services, such as cryopreservation and genotyping. Companies in the market include The Jackson Laboratory, Taconic Biosciences, TransGenic, and Charles River Laboratories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.